In addition, RHBDF2 upregulation was related to bad OS in American Joint Committee on Cancer (AJCC) stage T‐1 HCC patients, and related to unfavorable OS, bad RFS, poor PFS, poor DSS in AJCC stage T‐2 HCC patients, and associated with poor RFS in AJCC stage T‐3 HCC patients (Fig. 4A–D). The gene discussed is RHBDF2; the disease is hepatocellular carcinoma.